Tg Therapeutics
by mosley1234 | January 13, 2017 12:51 pm
To All,
I noticed that Michael Weiss, CEO of TG Therapeutics reduced his total share count considerably in 2016. He went from owning 4.5 million shares down to 1.1 million.
Maybe he had to unload them by a certain date, I am not that familiar with shares owned by insiders. Just wanted to bring it to everyone’s attention. maybe it is nothing to be concerned about but I was surprised when I noticed it.
Source URL: https://www.stockgumshoe.com/2017/01/microblog-tg-therapeutics/
$TGTX long – Please see the following most recent Form 4 Mosley http://ir.tgtherapeutics.com/secfiling.cfm?filingID=1354488-17-33&CIK=1001316
Read the explanation of responses.
$TGTX – This 8-K further clarifies Mr. Weiss’ employment with the company: http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11764651&RcvdDate=1/4/2017&CoName=TG%20THERAPEUTICS%2C%20INC.&FormType=8-K&View=html